Found: 19
Select item for more details and to access through your institution.
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0639-8
- By:
- Publication type:
- Article
Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 7, p. 1627, doi. 10.1007/s00277-020-04101-7
- By:
- Publication type:
- Article
Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 x 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10/L monoclonal lymphocytes better identifies subgroups with different outcomes.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 4, p. 627, doi. 10.1007/s00277-014-2263-1
- By:
- Publication type:
- Article
Induction (MATRix) Followed by Transplantation in Primary Central Nervous System Lymphoma. Experience of the GELTAMO (Grupo Español de Linfoma y Trasplante de Medula Ósea).
- Published in:
- Hematological Oncology, 2023, v. 41, p. 401, doi. 10.1002/hon.3164_293
- By:
- Publication type:
- Article
OUTCOME OF 133 PATIENTS WITH FOLLICULAR LYMPHOMA (FL) PROGRESSING BEFORE 24 MONTHS (POD24) AFTER IMMUNOCHEMOTHERAPY: A GELTAMO STUDY.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.27_2880
- By:
- Publication type:
- Article
A GENE SIGNATURE TO PREDICT RISK OF TRANSFORMATION IN PATIENTS WITH FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.16_2880
- By:
- Publication type:
- Article
Short course of R-HyperCVAD/MTX/ ARA-C followed by ASCT as first-line therapy in mantle cell lymphoma patients prolongs progression-free survival to more than 9 years.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 359, doi. 10.1002/hon.2439_113
- By:
- Publication type:
- Article
AUTOLOGOUS STEM CELL TRANSPLANTATION MAY POTENTIALLY ABROGATE THE NEGATIVE PROGNOSTIC EFFECT OF EARLY RELAPSE AFTER CHEMO OR INMUNOCHEMOTHERAPY IN FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 221, doi. 10.1002/hon.2438_85
- By:
- Publication type:
- Article
Effective treatments are required for patients with diffuse large B-cell lymphoma ( DLBCL) with primary refractory disease.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 344, doi. 10.1002/hon.2439_92
- By:
- Publication type:
- Article
Initial management of primary central nervous system lymphoma in Spain in the last decade. The experience of the GELTAMO and Spanish neuro-oncology groups.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 354, doi. 10.1002/hon.2439_107
- By:
- Publication type:
- Article
CD30 expression in diffuse large B-cell lymphoma correlates with non- GCB subtype but does not have prognostic impact in patients treated with first line R-CHOP/ R-CHOP-like.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 290, doi. 10.1002/hon.2439_19
- By:
- Publication type:
- Article
CLINICAL CHARACTERISTICS AND PROGNOSIS OF ELDERLY (>70 YEARS) FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA: MULTICENTRE RETROSPECTIVE ANALYSIS OF THE GELTAMO SPANISH GROUP.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 367, doi. 10.1002/hon.2439_122
- By:
- Publication type:
- Article
GENE MUTATIONS AND COPY NUMBER ALTERATIONS (CNA) PREDICT FOR EARLY FAILURE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-CHOP.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 93, doi. 10.1002/hon.2437_82
- By:
- Publication type:
- Article
PATIENTS WITH FOLLICULAR LYMPHOMA (FL) IN MAINTAINED COMPLETE RESPONSE (CR) AT 30 MONTHS SHOW A SURVIVAL SIMILAR TO A SEX- AND AGE-MATCHED SPANISH GENERAL POPULATION.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 226, doi. 10.1002/hon.2438_90
- By:
- Publication type:
- Article
PHASE 2 RANDOMIZED TRIAL COMPARING STANDARD RCHOP VERSUS BRCAP AS FIRST LINE TREATMENT IN YOUNG PATIENTS WITH HIGH-RISK DLBCL. A STUDY FROM SPANISH GROUP GELTAMO.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 188, doi. 10.1002/hon.2438_49
- By:
- Publication type:
- Article
Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 148, n. 3, p. 545, doi. 10.1007/s11060-020-03547-z
- By:
- Publication type:
- Article
Azacitidine adverse effects in patients with myelodysplastic syndromes.
- Published in:
- Advances in Therapy, 2011, v. 28, p. 6, doi. 10.1007/s12325-011-0024-2
- By:
- Publication type:
- Article